The parasiticides segment accounted for the highest share in 2017 with market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.
The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global veterinary drugs market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global veterinary drugs market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.
Some of the Main Key Players Covered in the Report:
- Intervet Inc.
- Boehringer Ingelheim
- Vetoquinol S.A.
- Bayer AG
- Other players
Major Table of Content for Veterinary Drugs Market:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1 Pipeline Analysis of Veterinary Drugs
4.2 Overview of Company Share Analysis
4.3 Overview of Strategies by Key Market Leaders
4.4 Key Industry Developments such as Mergers & Acquisitions
4.5 New Product Launches
4.6 Regulatory Scenario
4.7 Overview of Cost Analysis
Top Tranding [email protected]